These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 1133851

  • 1. Genetics of susceptibility to plasmacytoma induction. I. BALB/cAnN (C), C57BL/6N (B6), C57BL/Ka (BK), (C times B6)F1, (C times BK)F1, and C times B recombinant-inbred strains.
    Potter M, Pumphrey JG, Bailey DW.
    J Natl Cancer Inst; 1975 Jun; 54(6):1413-7. PubMed ID: 1133851
    [Abstract] [Full Text] [Related]

  • 2. Induction of plasmacytomas with silicone gel in genetically susceptible strains of mice.
    Potter M, Morrison S, Wiener F, Zhang XK, Miller FW.
    J Natl Cancer Inst; 1994 Jul 20; 86(14):1058-65. PubMed ID: 8021954
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficiency alleles of the Pctr1 modifier locus for plasmacytoma susceptibility.
    Zhang SL, DuBois W, Ramsay ES, Bliskovski V, Morse HC, Taddesse-Heath L, Vass WC, DePinho RA, Mock BA.
    Mol Cell Biol; 2001 Jan 20; 21(1):310-8. PubMed ID: 11113205
    [Abstract] [Full Text] [Related]

  • 7. Detection of immunoglobulin/c-myc recombinations in mice that are resistant to plasmacytoma induction.
    Müller JR, Jones GM, Potter M, Janz S.
    Cancer Res; 1996 Jan 15; 56(2):419-23. PubMed ID: 8542601
    [Abstract] [Full Text] [Related]

  • 8. Induction of plasma cell tumours with 2,6,10,14-tetramethylpentadecane (pristane) and paraffin oil (paraffinum perliquidum) in BALB/c mice simultaneously exposed to sustained antigenic stimulation with bovine serum albumin (BSA).
    Janz S, Püschel W, Raabe F, Storch H.
    Arch Geschwulstforsch; 1987 Jan 15; 57(1):25-30. PubMed ID: 3566462
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of plasmacytoma development in BALB/c mice by indomethacin.
    Potter M, Wax JS, Anderson AO, Nordan RP.
    J Exp Med; 1985 May 01; 161(5):996-1012. PubMed ID: 3989472
    [Abstract] [Full Text] [Related]

  • 10. Hybrid resistance to BALB/c plasmacytomas. I. Resistance to MPC-11 controlled by a locus not linked to H-2.
    Walker MC, Phillips-Quagliata JM.
    J Immunol; 1979 Apr 01; 122(4):1535-43. PubMed ID: 448097
    [Abstract] [Full Text] [Related]

  • 11. Identification of two genes on chromosome 4 that determine resistance to plasmacytoma induction in mice.
    Potter M, Mushinski EB, Wax JS, Hartley J, Mock BA.
    Cancer Res; 1994 Feb 15; 54(4):969-75. PubMed ID: 8313388
    [Abstract] [Full Text] [Related]

  • 12. Pristane induces an indomethacin inhibitable inflammatory influx of CD4+ T cells and IFN-gamma production in plasmacytoma-susceptible BALB/cAnPt mice.
    McDonald AH, Degrassi A.
    Cell Immunol; 1993 Jan 15; 146(1):157-70. PubMed ID: 8425224
    [Abstract] [Full Text] [Related]

  • 13. Plasmacytomagenesis in mice: model of neoplastic development dependent upon chromosomal translocations.
    Potter M, Wiener F.
    Carcinogenesis; 1992 Oct 15; 13(10):1681-97. PubMed ID: 1423827
    [Abstract] [Full Text] [Related]

  • 14. Comparison of patterns of hybrid resistance to the BALB/c plasmacytomas LPC-1 and MPC-11.
    Walker MC, Phillips-Quagliata JM.
    Cancer Immunol Immunother; 1985 Oct 15; 20(1):47-54. PubMed ID: 3851694
    [Abstract] [Full Text] [Related]

  • 15. Specific chromosome translocation in pristane-induced plasmacytomas of NZB mice.
    Oikawa T, Kuzumaki N, Yamada T.
    J Natl Cancer Inst; 1984 Feb 15; 72(2):347-53. PubMed ID: 6582321
    [Abstract] [Full Text] [Related]

  • 16. Peritoneal plasmacytomagenesis in mice: comparison of different pristane dose regimens.
    Potter M, Wax JS.
    J Natl Cancer Inst; 1983 Aug 15; 71(2):391-5. PubMed ID: 6576197
    [Abstract] [Full Text] [Related]

  • 17. BALB/c.CBA/N mice carrying the defective Btk(xid) gene are resistant to pristane-induced plasmacytomagenesis.
    Potter M, Wax JS, Hansen CT, Kenny JJ.
    Int Immunol; 1999 Jul 15; 11(7):1059-64. PubMed ID: 10383938
    [Abstract] [Full Text] [Related]

  • 18. Gas chromatographic-mass spectrometric investigation of four commercial pristane (2.6.10.14-tetramethylpentadecane) preparations used for plasmacytoma induction in BALB/c mice.
    Janz S, Birkenfeld T, Herzschuh R, Storch H.
    Arch Geschwulstforsch; 1989 Jul 15; 59(6):415-22. PubMed ID: 2596957
    [Abstract] [Full Text] [Related]

  • 19. Functional homology between N-myc and c-myc in murine plasmacytomagenesis: plasmacytoma development in N-myc transgenic mice.
    Wang Y, Sugiyama H, Axelson H, Panda CK, Babonits M, Ma A, Steinberg JM, Alt FW, Klein G, Wiener F.
    Oncogene; 1992 Jun 15; 7(6):1241-7. PubMed ID: 1375720
    [Abstract] [Full Text] [Related]

  • 20. BCL2 accelerates inflammation-induced BALB/c plasmacytomas and promotes novel tumors with coexisting T(12;15) and T(6;15) translocations.
    Silva S, Kovalchuk AL, Kim JS, Klein G, Janz S.
    Cancer Res; 2003 Dec 15; 63(24):8656-63. PubMed ID: 14695177
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.